Total Funding
35
14
Total FundingPost-IPO Equity raised
Growth Score 35 in past quarter
-5 pts
Heat Score 14 in past quarter
-10 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
3238074
Manhattan Scientifics focuses on the technology transfer and commercialization of disruptive technologies in the nanomedicine.
- Marvin Maslow: Founder
- Emmanuel Tsoupanarias: CEO and Chairman
About the Company
Manhattan Scientifics focuses on the technology transfer and commercialization of disruptive technologies in the nanomedicine. space in the United States. The company is developing commercial medical prosthetics applications for its ultra-fine grain metals; and plans to commercialize the cancer research work and nanomedical applications.
It was
founded in 1992 and headquartered in New York, United States.
